Roivant Sciences (NASDAQ:ROIV – Get Free Report) had its price target increased by equities researchers at Guggenheim from $36.00 to $42.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Guggenheim’s target price suggests a potential upside of 16.33% from the company’s [...]
Guggenheim Issues Positive Forecast for Roivant Sciences (NASDAQ:ROIV) Stock Price
